There is unmet healthcare need for a single drug with a dual action which single-handedly can control the dyslipidemia and provide glycemic benefits without side-effects. Pankaj Patel, Chairman and MD, Zydus Cadila in an exclusive interview with Ananya Sen answers all you wanted to know about Lipaglyn.